USE OF LEVOSIMENDAN FOR THE TREATMENT OR PREVENTION OF CORONARY GRAFT VASOSPASM

• 收藏
• 分享

专利权人:

ORION CORPORATION

发明人:

LEHTONEN, LASSE,PAPP, JULIUS GY.,SZECSI JANOS

申请号：

HU0202085

公开号：

HU228302B1

申请日:

2000.06.29

申请国别(地区):

HU

年份:

2013

代理人:

摘要：

Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]-propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment or prevention of coronary graft vasospasm after coronary artery by-pass surgery.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/